Create an Account

Best of 2020

Best of 2020

Best of 2020
RestartResume

A review and discussion of the key takeaways from three of the best articles in 2020 in the IBD Journal and Crohn’s & Colitis 360.

  • Overview

    Overview of main takeaways/clinical or research on three articles:

    • Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
    • The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    • Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences and Current Use in Australian Patients

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We’re glad to see you’re enjoying Crohn's Colitis Professional…
    but how about a more personalized experience?

    Register for free
    You are now leaving Crohn's Colitis Professional and going to a site run by another organization.

    Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.